Published in Cell Immunol on April 01, 1984
Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin 2 production and macrophage-mediated inhibitory effects. Infect Immun (1994) 1.14
Serum IL-2 inhibitor in mice. I. Increase during infection. Immunology (1985) 1.14
Impairment of lymphocyte proliferative responses and interleukin-2 production in susceptible (C57BL/6) mice infected with Salmonella typhimurium. Immunology (1986) 1.05
Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice. Infect Immun (1988) 0.99
Interleukin-1 and interleukin-2 production in resistant and susceptible inbred mice infected with Trypanosoma congolense. Immunology (1986) 0.92
Mechanisms underlying the depressed production of interleukin-2 in spleen and lymph node cell cultures of mice infected with Mycobacterium bovis BCG. Infect Immun (1986) 0.92
Suppression of interleukin-2 production by macrophages in genetically susceptible mice infected with Leishmania major. Infect Immun (1986) 0.92
Macrophage functions in Biozzi mice. Immunology (1985) 0.83
Macrophages expressing heat-shock protein 65 play an essential role in protection of mice infected with Plasmodium yoelii. Immunology (1999) 0.78
Sick individuals and sick populations. Int J Epidemiol (1985) 23.44
Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet (1976) 15.18
Inequalities in death--specific explanations of a general pattern? Lancet (1984) 13.99
Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) (1981) 11.00
Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. Lancet (1974) 10.02
Employment grade and coronary heart disease in British civil servants. J Epidemiol Community Health (1978) 8.58
Myocardial ischaemia, risk factors and death from coronary heart-disease. Lancet (1977) 6.97
Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med (1977) 6.15
The cellular basis of immunological responses. A synthesis of some current views. Lancet (1969) 6.05
Magnitude and causes of socioeconomic differentials in mortality: further evidence from the Whitehall Study. J Epidemiol Community Health (1990) 5.93
Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979. Br Med J (Clin Res Ed) (1985) 5.48
Social class and coronary heart disease. Br Heart J (1981) 5.43
Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet (1980) 4.86
Cold weather and ischaemic heart disease. Br J Prev Soc Med (1966) 4.25
UK heart disease prevention project: incidence and mortality results. Lancet (1983) 4.19
A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health (1982) 3.85
Mortality of employees of the Atomic Weapons Establishment, 1951-82. BMJ (1988) 3.82
Quantum annealing with manufactured spins. Nature (2011) 3.81
Incidence of cancers of the larynx and lung near incinerators of waste solvents and oils in Great Britain. Lancet (1992) 3.71
Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA (1992) 3.37
Weight and mortality in the Whitehall Study. Br Med J (Clin Res Ed) (1982) 3.35
Plasma lipids and mortality: a source of error. Lancet (1980) 3.34
Current management of hypertension in hospital. Br Med J (1977) 3.31
Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J (1978) 3.28
Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) (1983) 3.28
Alcohol and mortality: a U-shaped curve. Lancet (1981) 3.28
Focal antibody production by transferred spleen cells in irradiated mice. Science (1965) 3.12
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09
Heart disease prevention project: a randomised controlled trial in industry. Br Med J (1980) 3.03
Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology (1968) 2.98
What is epidemiology? Br Med J (1978) 2.96
The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ (1990) 2.71
Blood-sugar and arterial disease. Lancet (1965) 2.70
INTERSALT study findings. Public health and medical care implications. Hypertension (1989) 2.69
How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J (Clin Res Ed) (1984) 2.64
Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J (1999) 2.61
Variability of angina. Some implications for epidemiology. Br J Prev Soc Med (1968) 2.58
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
Findings of the International Cooperative INTERSALT Study. Hypertension (1991) 2.53
Cigarette smoking by hospital patients. Br J Prev Soc Med (1971) 2.53
Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study. Br Med J (Clin Res Ed) (1986) 2.52
Current management of hypertension in general practice. Br Med J (1977) 2.47
Malarial parasites induce TNF production by macrophages. Immunology (1988) 2.42
Alcohol and blood pressure: the INTERSALT study. BMJ (1994) 2.41
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis (2005) 2.33
Endotoxin-induced serum factor kills malarial parasites in vitro. Infect Immun (1981) 2.30
A cardiovascular survey of British postal workers. Lancet (1966) 2.25
Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation (1990) 2.15
The Small Area Health Statistics Unit: a national facility for investigating health around point sources of environmental pollution in the United Kingdom. J Epidemiol Community Health (1992) 2.15
Socioeconomic differentials in cancer among men. Int J Epidemiol (1991) 2.13
Hypertension. Br Med Bull (1971) 2.12
Blood pressure measurement in the United Kingdom Heart Disease Prevention Project. J Epidemiol Community Health (1978) 2.11
Induction of red cell autoantibodies in normal mice. Nat New Biol (1973) 2.09
Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J (1970) 2.09
Sick individuals and sick populations. 1985. Bull World Health Organ (2001) 2.05
Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis. Eur J Immunol (1989) 2.04
Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei. Immunology (1977) 2.03
Immunosuppressive potency and in-vitro activity of antilymphocyte globulin. Lancet (1969) 2.02
A randomised controlled trial of the effect on middle-aged men of advice to stop smoking. J Epidemiol Community Health (1978) 1.97
The specificity of autobiographical memory and imageability of the future. Mem Cognit (1996) 1.96
Cell cooperation in the immune response. Clin Exp Immunol (1971) 1.91
Quantitative assessment of exposure to dog (Can f 1) and cat (Fel d 1) allergens: relation to sensitization and asthma among children living in Los Alamos, New Mexico. J Allergy Clin Immunol (1995) 1.88
Cholesterol screening programmes: how much potential benefit? BMJ (1989) 1.87
Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol (1978) 1.82
Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor. Infect Immun (1982) 1.79
Suppressor T cells in experimental autoimmune haemolytic anaemia. Nature (1978) 1.79
Separate thymus dependent and thymus independent antibody forming cell precursors. Nat New Biol (1971) 1.78
Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology (1992) 1.78
Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology (1989) 1.77
Killing of human malaria parasites by macrophage secretory products. Infect Immun (1984) 1.76
A proposed trial of heart disease prevention in industry. Trans Soc Occup Med (1970) 1.75
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun (1997) 1.75
Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun (1983) 1.74
Risk of stroke in non-rheumatic atrial fibrillation. Lancet (1987) 1.73
Wide-complex tachycardia: continued evaluation of diagnostic criteria. Acad Emerg Med (2000) 1.71
Predicting coronary heart disease from minor symptoms and electrocardiographic findings. Br J Prev Soc Med (1971) 1.70
Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the United States. Int J Epidemiol (1989) 1.68
Cigarettes, lung cancer, and coronary heart disease: the effects of inhalation and tar yield. J Epidemiol Community Health (1982) 1.68
The role of antibody in T-cell responses. Clin Exp Immunol (1974) 1.67
Epidemiology for the uninitiated. Screening. Br Med J (1978) 1.65
The contribution of intensive coronary care. Br J Prev Soc Med (1975) 1.65
The role of the liver in immunity to blood-stage murine malaria. Immunology (1980) 1.65
Cell-mediated immunity in the liver of mice vaccinated against malaria. Nature (1979) 1.64
Physical activity and coronary heart disease. Proc R Soc Med (1969) 1.63
Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol (1987) 1.62
Blood pressure and associated factors in a rural Kenyan community. Hypertension (1985) 1.60
Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. J Allergy Clin Immunol (1989) 1.60
Rosette formation by mouse lymphocytes. III. Receptors for immunoglobulin on normal and activated T cells. Clin Exp Immunol (1974) 1.59
Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. Br Med J (Clin Res Ed) (1985) 1.58
Incubation period of coronary heart disease. Br Med J (Clin Res Ed) (1982) 1.57
Strain differences in the immune responses of mice. 3. A raised tolerance threshold in NZB thymus cells. Immunology (1971) 1.57
Population study of blood pressure and associated factors in St Lucia, West Indies. Int J Epidemiol (1982) 1.54
Specific tolerance to sheep erythrocytes in mouse bone marrow cells. Nature (1969) 1.52
Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum Genet (2001) 1.50
Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked. Lancet (1980) 1.50
Colon cancer and blood-cholesterol. Lancet (1974) 1.49
Prognosis in adult asthma: a national study. Br Med J (Clin Res Ed) (1987) 1.49
Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J (1987) 1.48
The purification and properties of microsomal palmitoyl-coenzyme A synthetase. Biochem J (1971) 1.48